4.8 Article

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

Patrick Marcellin et al.

JOURNAL OF HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis

Eugene Schiff et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Review Gastroenterology & Hepatology

Mechanisms of hepatic fibrogenesis

Scott L. Friedman

GASTROENTEROLOGY (2008)

Review Gastroenterology & Hepatology

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

Yun-Fan Liaw et al.

HEPATOLOGY INTERNATIONAL (2008)

Article Gastroenterology & Hepatology

Risk and predictors of mortality associated with chronic hepatitis B infection

Uchenna H. Iloeje et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)

Review Gastroenterology & Hepatology

Chronic hepatitis B

Anna S. F. Lok et al.

HEPATOLOGY (2007)

Review Medicine, Research & Experimental

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

John P. Iredale

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Gastroenterology & Hepatology

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

Stephanos J. Hadziyannis et al.

GASTROENTEROLOGY (2006)

Article Gastroenterology & Hepatology

Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study

Gang Chen et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Article Medicine, General & Internal

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

TT Chang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B

CL Lai et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Gastroenterology & Hepatology

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

UH Iloeje et al.

GASTROENTEROLOGY (2006)

Article Medicine, General & Internal

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

CJ Chen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Review Biochemistry & Molecular Biology

The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis

AM Elsharkawy et al.

APOPTOSIS (2005)

Article Oncology

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men

MW Yu et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)

Article Gastroenterology & Hepatology

Reversibility of Cirrhosis in Chronic Hepatitis B

Reza Malekzadeh et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)

Article Gastroenterology & Hepatology

High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection

K Ohata et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)

Article Medicine, General & Internal

Lamivudine for patients with chronic hepatitis B and advanced liver disease

YF Liaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Gastroenterology & Hepatology

Histological outcome during long-term lamivudine therapy

JL Dienstag et al.

GASTROENTEROLOGY (2003)

Article Medicine, General & Internal

Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation

P Muretto et al.

ANNALS OF INTERNAL MEDICINE (2002)

Article Medicine, General & Internal

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

Y Shiratori et al.

ANNALS OF INTERNAL MEDICINE (2000)

Article Gastroenterology & Hepatology

Is liver fibrosis reversible?

RC Benyon et al.